Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
iShares MSCI World ETF
URTH
$8.22B
| $459K | ﹤0.01% |
4,650
| – | – |
|
4302
Applied Optoelectronics
AAOI
$10.6B
| $458K | ﹤0.01% |
38,492
+12,493
| +48% | +$133K |
|
4303
PUT
Golar LNG
GLNG
$5.05B
| $458K | ﹤0.01% |
32,200
-23,200
| -42% | -$314K |
|
4304
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.75B
| $458K | ﹤0.01% |
17,000
| – | – |
|
4305
PUT
Tower Semiconductor
TSEM
$25.1B
| $457K | ﹤0.01% |
19,000
+7,300
| +62% | +$164K |
|
4306
Waterstone Financial
WSBF
$377M
| $457K | ﹤0.01% |
23,972
+11,633
| +94% | +$214K |
|
4307
PUT
Exelixis
EXEL
$14.1B
| $456K | ﹤0.01% |
25,900
-96,900
| -79% | -$1.64M |
|
|
TECX
4308
Tectonic Therapeutic
TECX
$557M
| $456K | ﹤0.01% |
1,889
+881
| +87% | +$170K |
|
4309
CALL
Wendy's
WEN
$1.48B
| $455K | ﹤0.01% |
20,500
-21,600
| -51% | -$458K |
|
|
CLPR
4310
Clipper Realty
CLPR
$43.9M
| $453K | ﹤0.01% |
42,682
+35,412
| +487% | +$338K |
|
4311
Utah Medical Products
UTMD
$226M
| $453K | ﹤0.01% |
4,189
+1,766
| +73% | +$179K |
|
|
HZNP
4312
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $453K | ﹤0.01% |
12,500
-800
| -6% | -$24.5K |
|
4313
CytomX Therapeutics
CTMX
$718M
| $452K | ﹤0.01% |
54,293
+27,774
| +105% | +$187K |
|
4314
Integra LifeSciences
IART
$1.38B
| $451K | ﹤0.01% |
7,755
+4,406
| +132% | +$262K |
|
|
VRTV
4315
DELISTED
VERITIV CORPORATION
VRTV
| $448K | ﹤0.01% |
22,739
+6,667
| +41% | +$116K |
|
4316
Foster
FSTR
$440M
| $447K | ﹤0.01% |
23,078
+4,995
| +28% | +$97.1K |
|
4317
CALL
Penske Automotive Group
PAG
$14.2B
| $447K | ﹤0.01% |
8,900
-22,100
| -71% | -$1.09M |
|
4318
PUT
Raymond James Financial
RJF
$34.6B
| $447K | ﹤0.01% |
7,500
| – | – |
|
|
ODT
4319
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $447K | ﹤0.01% |
13,786
+4,677
| +51% | +$145K |
|
|
COWN
4320
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $447K | ﹤0.01% |
28,365
+14,078
| +99% | +$211K |
|
4321
CRA International
CRAI
$1.14B
| $445K | ﹤0.01% |
8,184
+3,761
| +85% | +$183K |
|
4322
PUT
Designer Brands
DBI
$339M
| $444K | ﹤0.01% |
28,200
-2,200
| -7% | -$36.5K |
|
4323
CALL
Hecla Mining
HL
$11.2B
| $444K | ﹤0.01% |
131,100
+22,200
| +20% | +$54.5K |
|
|
KALV
4324
DELISTED
KalVista Pharmaceuticals
KALV
| $444K | ﹤0.01% |
24,896
+6,862
| +38% | +$89.6K |
|
4325
Beazer Homes USA
BZH
$929M
| $443K | ﹤0.01% |
31,361
+127
| +0.4% | +$1.93K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.